Ligand validation:1DZ9

TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1DZ9_TRS_A_504	93%	21%	0.072	0.966	1.84	1.48	3	1	0	0	100%	1
1DZ8_TRS_A_504	93%	12%	0.073	0.969	1.96	2.09	3	4	0	0	100%	1
1DZ6_TRS_A_503	89%	11%	0.075	0.955	1.92	2.31	3	4	0	0	100%	1
1DZ4_TRS_A_503	87%	20%	0.078	0.95	1.85	1.57	3	2	0	0	100%	1
2A1O_TRS_B_2430	78%	13%	0.085	0.927	1.92	2.03	3	4	0	0	100%	1
2A1N_TRS_B_2430	71%	12%	0.118	0.94	2.02	2.08	3	4	0	0	100%	1
4RT5_TRS_A_203	100%	58%	0.039	0.992	0.67	0.93	-	-	1	0	100%	1
1FHF_TRS_B_4001	100%	21%	0.034	0.986	1.79	1.55	1	2	0	0	100%	1
4MY0_TRS_F_401	100%	70%	0.04	0.981	0.33	0.82	-	-	0	0	100%	1
3IWF_TRS_B_109	100%	76%	0.043	0.983	0.38	0.55	-	-	0	0	100%	1
1EKV_TRS_B_371	99%	3%	0.036	0.992	0.59	5.3	-	4	2	0	88%	0.875

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.